There was a major interest in the last years in the design of anticancer agents containing the 1, 5-diaryl-3-oxo-1, 4-pentadienyl system. The modification of this pharmacophore by the introduction of an additional Michael acceptor represents a strategy to obtain novel potential antiproliferative agents. In a continuing study of hybrid compounds containing the α- bromoacryloyl moiety as potential anticancer drugs, we synthesized two novel series of ...